Cesca Therapeutics CEO Chris Xu's 2022 pay slips 7% to $699K

Cesca Therapeutics reports 2022 executive compensation

By ExecPay News

Published: October 26, 2023

Cesca Therapeutics reported fiscal year 2022 executive compensation information on October 26, 2023.
In 2022, three executives at Cesca Therapeutics received on average a compensation package of $526K, a 4% decrease compared to previous year.
Average pay of disclosed executives at Cesca Therapeutics
Chris Xu, Chief Executive Officer, received $699K in total, which decreased by 7% compared to 2021. 74% of Xu's compensation, or $519K, was in salary. Xu also received $180K in bonus.
Haihong Zhu, Chief Operating Officer, received a compensation package of $554K. 83% of the compensation package, or $458K, was in salary.
Jeffery Cauble, Chief Financial Officer, earned $325K in 2022, a 7% decrease compared to previous year.

Related executives

Chris Xu

Cesca Therapeutics

Chief Executive Officer

Jeffery Cauble

Cesca Therapeutics

Chief Financial Officer

Haihong Zhu

Cesca Therapeutics

Chief Operating Officer

You may also like

Source: SEC filing on October 26, 2023.